Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
DOI: 10.1038/npjbcancer.2016.24
Barbara L Smith,
Caryl G Salomon,
David E Einspahr,
David L Campbell,
Dawn Hershman,
Frank L Meyskens,
Garnet L Anderson,
Gary E Goodman,
Joseph M Unger,
Katherine D Crew,
Kathy S Albain,
Lucas Wong,
Powel H Brown,
Robert B Livingston,
Ronald K Potkul,
Sharon P Wilczynski
Abstract:
Full-Text